Goldman Sachs Upgrades AstraZeneca (NYSE: AZN) To Neutral

From: TradeTheTrend

Added: 16 years ago · 0:42 · 480p

2/26/2010- Goldman Sachs upgraded AstraZeneca (NYSE:AZN) from "sell" to "neutral," citing the company stock's ...